Kyowa Hakko USA
North American sales office for branded ingredients such as citicoline, glutathione and pantethine.
- MOQ
- Not publicly disclosed
- LEAD TIME
- Not publicly disclosed
Overview
Kyowa Hakko USA is the North American sales office for Kyowa Hakko Bio Co., Ltd., a global leader in branded ingredient development and manufacturing. Based in New York, they supply clinically researched, patented ingredients to the dietary supplement and functional food industries. Key branded ingredients include Cognizin (citicoline for brain health), Setria (glutathione), Pantesin (pantethine for cardiovascular health), and Sustamine (L-Alanyl-L-Glutamine for hydration). Kyowa is known for proprietary fermentation technology and maintaining high-quality standards. Their ingredients are backed by published clinical research.
Certifications
0 of 1 certification independently confirmed. What this means
Capabilities
- PRODUCT TYPES
- Citicoline (Cognizin) · Glutathione (Setria) · Pantethine (Pantesin) · L-Alanyl-L-Glutamine (Sustamine)
- CAPABILITIES
- Branded or patented ingredients · Clinical research or study support · Fermentation or culture-grown ingredients · Custom development or formulation help
Sources
- Kyowa Hakko USA - Official Website(2026-03-26)
- Kyowa Hakko USA - Contact(2026-03-26)
- Branded Ingredients Directory(2026-03-26)
- American Society for Nutrition - Profile(2026-03-26)
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Kyowa Hakko USA is a sales office; manufacturing is conducted by parent company Kyowa Hakko Bio Co., Ltd. in Japan
- Financial stability not independently assessed (parent company is a subsidiary of Kirin Holdings)
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
Disclosures
- Kyowa Hakko Bio Co., Ltd. is a subsidiary of Kirin Holdings Company, Limited (publicly traded: TYO: 2503)
The connection map between Kyowa Hakko USA and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Our Evaluation Method
A full assessment applies six checks. Source-Checked listings get a lighter review.
- Independent confirmation: Claims backed by documentation, not marketing copy
- How recent the data is: Information reviewed and dated within the last 12 months
- Sources we traced: Sources cited for every key claim
- Inconsistencies flagged: Where a company's claims and public records disagree, we say so
- What we disclose: Material connections stated directly on affected listings
- What we don't know: When we can't assess something, we say so explicitly
Interested in Kyowa Hakko USA?
Tell us about your project and we'll help you determine if this ingredient supplier is a good fit.